Aprea Therapeutics(APRE) - 2024 Q3 - Quarterly Results

| --- | --- | --- | |-----------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|--------------------------------------------------| | SECURITIES | UNITED STATES AND EXCHANGE COMMISSION Washington, D.C. 20549 | | | | FORM 8-K | | | | CURRENT REPORT | | | | Pursuant to Section 13 or 15(d) Securities Exchange Act of 1934 | | | | October 9, 2024 Report (Date of earliest event reported) | | | (Ex ...